37
Sofinnova BioEquities Enhanced Offshore Fund files amendment after raising $226.25M
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $226.3M · Grand Cayman, Cayman Islands · filed 2026-10-09
3(c)(7) — qualified purchasers
37
Sofinnova BioEquities Enhanced Offshore Fund Ltd. updates its Form D — $226.3M sold
Fund raise update · Hedge fund · Open-ended · Grand Cayman, Cayman Islands · Form D/A filed 2025-10-10 · all Sofinnova Bioequities Enhanced vehicles
$100M+ sold3(c)(7) — qualified purchasers
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| Cary Marr | Director |
| -- Sofinnova Investments, Inc. | Investment Manager |
| Paul Stevenson | Director |
| Eric Delbridge | Director |
Signed by Jim Brody, Chief Compliance Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
37
Sofinnova BioEquities Enhanced Offshore Fund Ltd. updates its Form D — $226.3M sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $226.3M · GRAND CAYMAN, CA · filed 2024-10-11
3(c)(7) — qualified purchasers